查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1980185

畜牧疫苗市場規模、佔有率、成長率及全球市場分析：按類型、應用和地區分類，並預測至2026-2034年

Livestock Vaccines Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 150 Pages | 商品交期: 請詢問到貨日

價格

畜牧疫苗市場成長要素

全球畜牧疫苗市場預計在2025年達到63.3億美元，2026年成長至66.8億美元，並在2034年達到113.9億美元，預測期內複合年成長率（CAGR）為6.9%。北美地區在2025年將佔市場主導地位，市場佔有率達46.90%，這主要得益於其大規模的畜牧存欄量、政府主導的疫苗接種計劃以及先進疫苗的普及。預計到2032年，美國畜牧疫苗市場規模將達到42.9億美元，主要得益於持續的研發投入以及政府為改善動物健康而採取的各項措施。

市場概覽

畜禽疫苗在保護牲畜免受口蹄疫、牛傳染性鼻氣管炎（IBR）、新城疫和豬繁殖與呼吸綜合症（PRRS）等感染疾病發揮著至關重要的作用。疫苗可透過多種途徑接種，包括注射、口服、鼻腔和皮下注射，並有多種形式，包括減毒活病毒疫苗疫苗、不活化疫苗、重組疫苗和類毒素疫苗。這些疫苗有助於減少與牲畜疾病相關的經濟損失，並保障全球糧食安全。

市場促進因素

通用病的日益流行推動了市場成長，這些感染疾病可從動物傳染給人類。這迫使各國政府和畜牧業主實施預防性疫苗接種計畫。在美國，每年約有5000例動物狂犬病病例報告，其中超過90%發生在野生動物身上，凸顯了畜牧疫苗的迫切需求。農民對動物保健和疫苗接種益處的認知不斷提高，也促進了市場成長。

主要企業的研發投入也正在推動市場擴張。各公司正投資開發先進疫苗，例如蛋白質次單元疫苗和重組疫苗，以應對新出現的感染疾病並增強牲畜的免疫反應。例如，勃林格殷格翰公司推出了VAXXITEK HVT+IBD+ILT，這是一種用於預防家禽馬立克氏病、傳染性咽炎腱鞘炎和傳染性喉氣管炎的重組疫苗。

市場限制因素

儘管市場存在成長機遇，但疫苗相關副作用也為市場帶來了挑戰。減毒活疫苗有時會引起輕微反應，某些疫苗對目標疾病的有效性可能有限。這些問題可能會降低畜牧養殖戶的疫苗採用率，並減緩部分地區的市場成長。

市場區隔

依類型：

  • 到 2026 年，減毒活病毒疫苗將佔市場主導地位，佔市場佔有率的 38.93%，這得益於其強大而持久的免疫反應。
  • 受家禽和豬病防治領域創新和日益普及的推動，重組疫苗預計將在 2026 年至 2034 年間實現最高的複合年成長率。
  • 去活化疫苗和其他類型的疫苗也促進了市場成長。

動物種類：

  • 到 2026 年，在全球牛數量成長的推動下，牛疫苗將佔最大的市場佔有率，達到 58%。
  • 由於疾病爆發的蔓延，預計 2025 年至 2032 年間，家禽疫苗的複合年成長率將最高。
  • 由於豬繁殖與呼吸綜合症（PRRS）和豬流感的爆發，豬疫苗繼續發揮重要作用。

依管理途徑：

  • 到 2026 年，能夠提供可靠免疫反應和快速療效的注射疫苗將佔最大佔有率，達到 67.16%。
  • 由於技術創新和臨床試驗的增加，口服疫苗正在發展壯大。
  • 其他給藥途徑，如鼻內給藥，僅限於特定用途。

依分銷管道：

  • 到 2024 年，動物醫院將佔市場主導地位，由於牲畜患者數量增加和獸醫招聘成功，它們將繼續保持主導地位。
  • 獸醫院正在擴張，特別是疫苗接種後的護理。

區域趨勢

北美：預計2025年市場規模將達29.7億美元，2026年將達31.3億美元。這主要得益於疫苗的上市、先進產品的應用以及大規模的牲畜存欄量。美國市場預計2026年將達29億美元。

歐洲：市場預計將穩定成長，主要受家禽和生豬引進、通用感染疾病傳播以及政府宣傳宣傳活動的影響。預計到2026年，英國和德國市場規模將分別達到2.4億美元和3.3億美元。

亞太地區：受中國、印度和日本疫苗接種計劃和宣傳活動的推動，該地區預計將實現最高的複合年成長率。預計2026年，日本市場規模將達2.5億美元，中國為2.8億美元，印度為1億美元。

拉丁美洲、中東和非洲：由於牲畜疾病的增加、疫苗技術的引入以及動物保健基礎設施的發展，市場佔有率正在擴大。

主要市場參與者

主要企業包括碩騰服務有限公司（Zoetis Services LLC）、默克動物保健（Merck Animal Health）、勃林格殷格翰國際有限公司（Boehringer Ingelheim International GmbH）、維克（Virbac）、西瓦（Ceva）、禮來（Elanco）和HIPRA。這些公司正致力於研發、新產品上市、併購和市場擴張，以鞏固其全球地位。諸如夥伴關係、收購和新疫苗研發等策略性措施是確立市場領導地位的關鍵。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第4章：主要考慮因素

  • 動物疫苗接種率：主要條件
  • 免疫接種計劃概述
  • 產業重大發展、合併、收購及合作。
  • 新冠疫情的影響：畜牧疫苗市場

第5章：2021-2034年全球畜牧疫苗市場分析、洞察與預測

  • 市場分析、洞察與預測：依類型
    • 失活
    • 減毒活病毒疫苗
    • 重組
    • 其他
  • 市場分析、洞察與預測：依動物類型分類
    • 牛
    • 豬
    • 家禽
    • 其他
  • 市場分析、洞察與預測：依給藥途徑
    • 口服
    • 腸外
    • 其他
  • 市場分析、洞察與預測：依分銷管道分類
    • 動物醫院
    • 動物診所
    • 其他
  • 市場分析、洞察與預測：依地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美畜牧疫苗市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲畜牧疫苗市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區畜牧疫苗市場分析、洞察與預測（2021-2034年）

  • 國家
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲畜牧疫苗市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東和非洲畜牧疫苗市場分析、洞察與預測（2021-2034年）

  • 國家
    • 南非
    • GCC
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • Boehringer Ingelheim International GmbH
    • Virbac
    • Merck Animal Health（Merck & Co., Inc.）
    • Zoetis Services LLC
    • Ceva
    • Elanco
    • Nisseiken Co., Ltd.
    • Neogen Corporation
Product Code: FBI101418

Growth Factors of livestock vaccines Market

The global livestock vaccines market was valued at USD 6.33 billion in 2025 and is projected to grow to USD 6.68 billion in 2026, reaching USD 11.39 billion by 2034, registering a CAGR of 6.9% during the forecast period. North America dominated the market in 2025 with a 46.90% share, driven by a large livestock population, government-backed vaccination programs, and the widespread adoption of advanced vaccines. The U.S. livestock vaccines market is expected to reach USD 4.29 billion by 2032, supported by ongoing R&D initiatives and government efforts to promote animal health.

Market Overview

Livestock vaccines play a crucial role in protecting farm animals from infectious diseases such as foot-and-mouth disease, infectious bovine rhinotracheitis (IBR), Newcastle disease, and porcine reproductive and respiratory syndrome (PRRS). Vaccines are administered through various routes, including parenteral, oral, intranasal, and subcutaneous, and are available in multiple forms such as live attenuated, inactivated, recombinant, and toxoid vaccines. These vaccines help reduce economic losses associated with livestock illnesses and support global food security.

Market Drivers

The market growth is fueled by the rising prevalence of zoonotic diseases, which can transmit from animals to humans, prompting governments and livestock owners to adopt preventive vaccination programs. In the U.S., around 5,000 animal rabies cases are reported annually, with over 90% occurring in wildlife, highlighting the critical need for livestock vaccines. Increasing awareness among farmers about animal healthcare and the benefits of immunization is further contributing to market growth.

R&D initiatives by major players also drive market expansion. Companies are investing in the development of advanced vaccines, such as protein subunit vaccines and recombinant vaccines, to address emerging diseases and enhance immune responses in livestock. For instance, Boehringer Ingelheim introduced VAXXITEK HVT+IBD+ILT, a recombinant vaccine for poultry protection against Marek's disease, infectious bursal disease, and infectious laryngotracheitis.

Market Restraints

Despite growth opportunities, the market faces challenges from adverse effects associated with vaccines. Live-attenuated vaccines may sometimes cause mild reactions, while certain vaccines show limited efficacy against targeted diseases. Such concerns can reduce the adoption rate among livestock owners and temper market growth in some regions.

Market Segmentation

By Type:

  • Live attenuated vaccines dominated the market in 2026 with a 38.93% share, due to strong and long-lasting immune responses.
  • Recombinant vaccines are expected to witness the highest CAGR from 2026 to 2034, driven by innovation and increasing adoption for poultry and swine protection.
  • Inactivated vaccines and others also contribute to market growth.

By Animal Type:

  • Bovine vaccines accounted for the largest share in 2026 at 58%, supported by the increasing global cattle population.
  • Poultry vaccines are projected to grow at the highest CAGR over 2025-2032 due to rising disease prevalence.
  • Swine/porcine vaccines remain significant due to outbreaks of PRRS and swine influenza.

By Route of Administration:

  • Parenteral vaccines held the largest share in 2026 at 67.16%, providing reliable immune responses and rapid onset.
  • Oral vaccines are growing due to innovation and increasing clinical trials.
  • Other routes, such as intranasal, are limited to specific use cases.

By Distribution Channel:

  • Veterinary clinics dominated in 2024 and continue to lead due to growing livestock visits and availability of veterinarians.
  • Veterinary hospitals are expanding, particularly for post-vaccination care.

Regional Insights

North America: Market size of USD 2.97 billion in 2025, projected USD 3.13 billion in 2026, driven by vaccine launches, adoption of advanced products, and large livestock populations. U.S. market projected to reach USD 2.9 billion in 2026.

Europe: Steady growth driven by poultry and swine adoption, zoonotic disease prevalence, and government awareness campaigns. UK and Germany markets projected at USD 0.24 billion and USD 0.33 billion in 2026, respectively.

Asia Pacific: Highest CAGR expected, led by vaccination programs and awareness initiatives in China, India, and Japan. Markets projected at Japan USD 0.25 billion, China USD 0.28 billion, and India USD 0.10 billion in 2026.

Latin America & Middle East & Africa: Growing market share due to increasing livestock diseases, technological vaccine launches, and enhanced animal healthcare infrastructure.

Key Market Players

Leading companies include Zoetis Services LLC, Merck Animal Health, Boehringer Ingelheim International GmbH, Virbac, Ceva, Elanco, and HIPRA, focusing on R&D, new product launches, mergers, and market expansion to strengthen their global presence. Strategic initiatives such as partnerships, acquisitions, and novel vaccine development are key for market leadership.

Conclusion

The livestock vaccines market is projected to grow from USD 6.33 billion in 2025 to USD 11.39 billion by 2034, driven by rising zoonotic disease prevalence, government initiatives, R&D investment, and technological advancements in vaccine development. Adoption across bovine, poultry, and swine populations, along with increasing awareness and improved vaccination programs, positions the market for sustained growth globally.

Segmentation

By Type

  • Inactivated
  • Live Attenuated
  • Recombinant
  • Others

By Animal Type

  • Bovine
  • Swine/ Porcine
  • Poultry
  • Others

By Route of Administration

  • Oral
  • Parenteral
  • Others

By Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Others

By Geography

  • North America (By Type, Animal Type, By Route of Administration, By Distribution Channel, and By Country)
    • U.S.
    • Canada
  • Europe (By Type, Animal Type, By Route of Administration, By Distribution Channel, and By Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, Animal Type, By Route of Administration, By Distribution Channel, and By Country/Sub-region)
    • China
    • India
    • Japan
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, Animal Type, By Route of Administration, By Distribution Channel, and By Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of the Latin America
  • Middle East & Africa (By Type, Animal Type, By Route of Administration, By Distribution Channel, and By Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Veterinary Vaccination Rates: Key Conditions
  • 4.2. Overview on Vaccination Programs
  • 4.3. Key Industry Developments, Mergers, Acquisitions, Partnerships, etc.
  • 4.4. Impact of COVID-19 Pandemic on Livestock Vaccines Market

5. Global Livestock Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Inactivated
    • 5.1.2. Live Attenuated
    • 5.1.3. Recombinant
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Animal Type
    • 5.2.1. Bovine
    • 5.2.2. Swine/ Porcine
    • 5.2.3. Poultry
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.3.1. Oral
    • 5.3.2. Parenteral
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.4.1. Veterinary Hospitals
    • 5.4.2. Veterinary Clinics
    • 5.4.3. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Livestock Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Inactivated
    • 6.1.2. Live Attenuated
    • 6.1.3. Recombinant
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Animal Type
    • 6.2.1. Bovine
    • 6.2.2. Swine/ Porcine
    • 6.2.3. Poultry
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.3.1. Oral
    • 6.3.2. Parenteral
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.4.1. Veterinary Hospitals
    • 6.4.2. Veterinary Clinics
    • 6.4.3. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Livestock Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Inactivated
    • 7.1.2. Live Attenuated
    • 7.1.3. Recombinant
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Animal Type
    • 7.2.1. Bovine
    • 7.2.2. Swine/ Porcine
    • 7.2.3. Poultry
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.3.1. Oral
    • 7.3.2. Parenteral
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.4.1. Veterinary Hospitals
    • 7.4.2. Veterinary Clinics
    • 7.4.3. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. United Kingdom
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Livestock Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Inactivated
    • 8.1.2. Live Attenuated
    • 8.1.3. Recombinant
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Animal Type
    • 8.2.1. Bovine
    • 8.2.2. Swine/ Porcine
    • 8.2.3. Poultry
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.3.1. Oral
    • 8.3.2. Parenteral
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.4.1. Veterinary Hospitals
    • 8.4.2. Veterinary Clinics
    • 8.4.3. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. China
    • 8.5.2. India
    • 8.5.3. Japan
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Livestock Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Inactivated
    • 9.1.2. Live Attenuated
    • 9.1.3. Recombinant
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Animal Type
    • 9.2.1. Bovine
    • 9.2.2. Swine/ Porcine
    • 9.2.3. Poultry
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.3.1. Oral
    • 9.3.2. Parenteral
  • 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.4.1. Veterinary Hospitals
    • 9.4.2. Veterinary Clinics
    • 9.4.3. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Livestock Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Inactivated
    • 10.1.2. Live Attenuated
    • 10.1.3. Recombinant
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Animal Type
    • 10.2.1. Bovine
    • 10.2.2. Swine/ Porcine
    • 10.2.3. Poultry
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.3.1. Oral
    • 10.3.2. Parenteral
  • 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.4.1. Veterinary Hospitals
    • 10.4.2. Veterinary Clinics
    • 10.4.3. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. South Africa
    • 10.5.2. GCC
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Boehringer Ingelheim International GmbH
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Virbac
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Merck Animal Health (Merck & Co., Inc.)
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Zoetis Services LLC
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Ceva
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Elanco
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Nisseiken Co., Ltd.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Neogen Corporation
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Livestock Vaccines Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2: Global Livestock Vaccines Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
  • Table 3: Global Livestock Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 4: Global Livestock Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 5: Global Livestock Vaccines Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Livestock Vaccines Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 7: North America Livestock Vaccines Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
  • Table 8: North America Livestock Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 9: North America Livestock Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 10: North America Livestock Vaccines Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Livestock Vaccines Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 12: Europe Livestock Vaccines Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
  • Table 13: Europe Livestock Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 14: Europe Livestock Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 15: Europe Livestock Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Asia Pacific Livestock Vaccines Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 17: Asia Pacific Livestock Vaccines Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
  • Table 18: Asia Pacific Livestock Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 19: Asia Pacific Livestock Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 20: Asia Pacific Livestock Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Latin America Livestock Vaccines Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 22: Latin America Livestock Vaccines Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
  • Table 23: Latin America Livestock Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 24: Latin America Livestock Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 25: Latin America Livestock Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Middle East & Africa Livestock Vaccines Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 27: Middle East & Africa Livestock Vaccines Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
  • Table 28: Middle East & Africa Livestock Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 29: Middle East & Africa Livestock Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 30: Middle East & Africa Livestock Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Livestock Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Livestock Vaccines Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Livestock Vaccines Market Value Share (%), by Animal Type, 2025 & 2034
  • Figure 4: Global Livestock Vaccines Market Value Share (%), by Route of Administration, 2025 & 2034
  • Figure 5: Global Livestock Vaccines Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 6: Global Livestock Vaccines Market Value (USD billion), by Region, 2025 & 2034
  • Figure 7: North America Livestock Vaccines Market Value (USD billion), by Type, 2025 & 2034
  • Figure 8: North America Livestock Vaccines Market Value Share (%), by Type, 2025
  • Figure 9: North America Livestock Vaccines Market Value (USD billion), by Animal Type, 2025 & 2034
  • Figure 10: North America Livestock Vaccines Market Value Share (%), by Animal Type, 2025
  • Figure 11: North America Livestock Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 12: North America Livestock Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 13: North America Livestock Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 14: North America Livestock Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 15: North America Livestock Vaccines Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Livestock Vaccines Market Value Share (%), By Country, 2025
  • Figure 17: Europe Livestock Vaccines Market Value (USD billion), by Type, 2025 & 2034
  • Figure 18: Europe Livestock Vaccines Market Value Share (%), by Type, 2025
  • Figure 19: Europe Livestock Vaccines Market Value (USD billion), by Animal Type, 2025 & 2034
  • Figure 20: Europe Livestock Vaccines Market Value Share (%), by Animal Type, 2025
  • Figure 21: Europe Livestock Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 22: Europe Livestock Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 23: Europe Livestock Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 24: Europe Livestock Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 25: Europe Livestock Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Livestock Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Livestock Vaccines Market Value (USD billion), by Type, 2025 & 2034
  • Figure 28: Asia Pacific Livestock Vaccines Market Value Share (%), by Type, 2025
  • Figure 29: Asia Pacific Livestock Vaccines Market Value (USD billion), by Animal Type, 2025 & 2034
  • Figure 30: Asia Pacific Livestock Vaccines Market Value Share (%), by Animal Type, 2025
  • Figure 31: Asia Pacific Livestock Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 32: Asia Pacific Livestock Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 33: Asia Pacific Livestock Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 34: Asia Pacific Livestock Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 35: Asia Pacific Livestock Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Livestock Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Livestock Vaccines Market Value (USD billion), by Type, 2025 & 2034
  • Figure 38: Latin America Livestock Vaccines Market Value Share (%), by Type, 2025
  • Figure 39: Latin America Livestock Vaccines Market Value (USD billion), by Animal Type, 2025 & 2034
  • Figure 40: Latin America Livestock Vaccines Market Value Share (%), by Animal Type, 2025
  • Figure 41: Latin America Livestock Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 42: Latin America Livestock Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 43: Latin America Livestock Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 44: Latin America Livestock Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 45: Latin America Livestock Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Livestock Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Livestock Vaccines Market Value (USD billion), by Type, 2025 & 2034
  • Figure 48: Middle East & Africa Livestock Vaccines Market Value Share (%), by Type, 2025
  • Figure 49: Middle East & Africa Livestock Vaccines Market Value (USD billion), by Animal Type, 2025 & 2034
  • Figure 50: Middle East & Africa Livestock Vaccines Market Value Share (%), by Animal Type, 2025
  • Figure 51: Middle East & Africa Livestock Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 52: Middle East & Africa Livestock Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 53: Middle East & Africa Livestock Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 54: Middle East & Africa Livestock Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 55: Middle East & Africa Livestock Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Livestock Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Livestock Vaccines Market Share (%), By Company, 2025